While the effects of LAP-mediated signaling on the MS disease outcome were clearly demonstrated in this study, no evidence was given that Nox3-derived ROS were responsible for the observed enhanced oxidative distress in the spinal cord. Here, NOX3 is linked to myeloid sarcoma.